Federal Register Notices  > Manufacturers Notice of Application - 2010  >  Lin Zhi International Inc.

Information and Legal Resources Banner

Notice of Application - 2010


FR Doc 2010-15516[Federal Register: June 28, 2010 (Volume 75, Number 123)]
[Notices]
[Page 36679-36680]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28jn10-94]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 8, 2010, Lin Zhi International Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug Schedule
Tetrahydrocannabinols (7370)  I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)  I
Cocaine (9041)  II
Oxycodone (9143)  II
Hydrocodone (9193)  II
Methadone (9250)  II
Dextropropoxyphene, bulk (non-dosage forms) (9273)  II
Morphine (9300)  II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.


Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 27, 2010.

Dated: June 17, 2010.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2010-15516 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).

DEA: Drug Enforcement Administration Home